Link to this page
BioModels Ontology
Last uploaded:
April 3, 2012
Jump to:
| Preferred Name | esmolol | |
| Synonyms |
|
|
| Definitions |
Methyl 3-(4-hydroxyphenyl)propanoate in which the hydrogen attached to the phenoic hydroxy group is substituted by a 2-hydroxy-3-(isopropylamino)propyl group. A cardioselective and short-acting beta1 receptor blocker with rapid onset but lacking intrinsic sympathomimetic and membrane-stabilising properties, it is used as the hydrochloride salt in the management of supraventricular arrhythmias, and for the control of hypertension and tachycardia during surgery. |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_4856 |
|
| alternative term |
methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3 ESMOLOL esmolol Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate InChIKey=AQNDDEOPVVGCPG-UHFFFAOYSA-N 3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate Esmolol C16H25NO4 (+-)-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate (+-)-esmolol COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1
|
|
| definition |
Methyl 3-(4-hydroxyphenyl)propanoate in which the hydrogen attached to the phenoic hydroxy group is substituted by a 2-hydroxy-3-(isopropylamino)propyl group. A cardioselective and short-acting beta1 receptor blocker with rapid onset but lacking intrinsic sympathomimetic and membrane-stabilising properties, it is used as the hydrochloride salt in the management of supraventricular arrhythmias, and for the control of hypertension and tachycardia during surgery.
|
|
| has functional parent | ||
| has role | ||
| label |
esmolol
|
|
| prefixIRI |
CHEBI:4856
|
|
| prefLabel |
esmolol
|
|
| subClassOf |
http://purl.obolibrary.org/obo/CHEBI_23981 |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping